Nutex Health Inc.
Close on Oct 19, 2026
- Market cap
- $1.34B
- P/E (TTM)
- 7.5
- Dividend yield
- –
Earnings
Next report expected Nov 17, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | During market hours | $210.80M | $9.38 | – |
| Q1 FY2026 Ended Mar 31, 2026 | Apr 30, 2026 | During market hours | $216.50M | $6.52 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 5, 2026 | During market hours | $151.70M | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 18, 2025 | During market hours | $257.60M | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 14, 2025 | During market hours | $244.00M | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 13, 2025 | During market hours | $211.80M | $2.56 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 31, 2025 | During market hours | $257.60M | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | During market hours | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 8, 2024 | During market hours | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 9, 2024 | During market hours | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 28, 2024 | During market hours | – | – | – |
Press releases
Announcements Nutex Health filed with the SEC
NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT
Other events · EX-99.1 to Form 8-K
NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH PROVIDES CORPORATE UPDATE
Results of operations · Listing notice · EX-99.1 to Form 8-K
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE
Results of operations · Listing notice · Prior financials no longer reliable · Other events · EX-99.1 to Form 8-K
NUTEX HEALTH reports FIRST quarter 2025 financial results
Results of operations · EX-99 to Form 8-K
NUTEX HEALTH reports FOURTH quarter and FULL year 2024 financial results
Results of operations · EX-99 to Form 8-K
Health Issues No Surprises Act (NSA) Arbitration Update
Other events · EX-99.1 to Form 8-K
NUTEX HEALTH reports third quarter and year to date September 30, 2024 financial results
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH reports SECOND quarter and Six months ended June 30, 2024 financial results
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH reports FIRST quarter 2024 financial results
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH reports fourth quarter and Full YEAR 2023 financial results
Results of operations · EX-99 to Form 8-K
of the date of this Current Report, the Company updates and supplements the risk factors disclosed
Material agreement · Other events · EX-99.1 to Form 8-K
S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L
Regulation FD disclosure · EX-99.1 to Form 8-K
NUTEX HEALTH reports THIRd quarter 2023 financial results
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JOSHUA DETILLIO AS ITS NEW
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
NUTEX HEALTH ANNOUNCES THE ACQUISITION OF POPULATION HEALTH ASSOCIATES
Other events · EX-99.1 to Form 8-K
NUTEX HEALTH reports Second quarter 2023 financial results
Results of operations · EX-99.1 to Form 8-K
NUTEX HEALTH reports FIRST quarter 2023 financial results
Results of operations · EX-99.1 to Form 8-K
S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L
Regulation FD disclosure · EX-99.1 to Form 8-K
HEALTH announces that it has entered into a $100 million pre-paid
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Lincoln Park Capital Fund, LLC
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
HEALTH announces change to its board of directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
NUTEX HEALTH Inc. reports fourth quarter and Full YEAR 2022 financial results
Results of operations · Other events · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Other events · EX-99.2 to Form 8-K
Nutex Health Inc. Investor Presentation.
Regulation FD disclosure · EX-99.1 to Form 8-K
at the 41 st Annual J.P. Morgan Healthcare conference
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · EX-99.2 to Form 8-K
HEALTH reports THIRD quarter 2022 financial results and announces
Results of operations · EX-99.1 to Form 8-K
TX − (PRNewswire) – October 10, 2022 – Nutex Health Inc. (“Nutex Health” or the “Company”)
Other events · EX-99.1 to Form 8-K
HEALTH reports secONd quarter 2022 financial results
Results of operations · EX-99.1 to Form 8-K
Health Inc. (“Nutex Health” or the “Company”), is a physician-led, technology-enabled healthcare services company
Acquisition or disposition completed · Other events · EX-99.1 to Form 8-K/A
HEALTH HOLDCO, LLC AND AFFILIATES
Acquisition or disposition completed · Other events · EX-99.2 to Form 8-K/A